期刊文献+

复方花刺参制剂对高脂模型大鼠血液流变学的改善 被引量:1

The Improvement of Stichopus Variegates Compound on Model Rats with Hyperlipidemia
下载PDF
导出
摘要 采用血液流变学检测方法 ,观察了复方花刺参制剂对高脂血症模型大鼠血粘度及其体外血栓的影响。结果发现此制剂具有明显的抗体外血栓形成和降低血粘度的作用 ,实验组与模型组大鼠在全血比粘度及体外血栓的长度、湿重和干重方面均存在着显著差异 (P <0 0 5 )。提示复方花刺参制剂能显著改善高脂模型大鼠的血液流变状态。 This study detected the effects of Stichopus Variegates Compound(SVC)on hemorheological variables of hyperlipidemia model rats.The results show that SVC can significantly alter the blood viscosity and resist the formation of thrombus in model rats with hyperlipidemia.The rats in experiment group treated with SVC have decreased in length,wet and dry weight of thrombus and their blood viscosities have been ameliorated compared with those in control group treated with water.This suggested that this compound could improve the hemorrheologic status of hyperlipidemia model rats notably.
出处 《生物医学工程研究》 2002年第1期27-28,共2页 Journal Of Biomedical Engineering Research
关键词 复方花刺参 血液流变学 高脂血症 Stichopus Variegates Compound Hemorrheology Hyperlipidemia
  • 相关文献

参考文献6

  • 1[1]Ramakrishnan S,Grebe R,Singh M.Evaluation of hemorrheological risk factor profile in plasmacytoma patients.Schmid-Schonbein H.Clin Hemorrheol Microcirc, 1999,20(1):11~9 被引量:1
  • 2[2]Lawall H,Angelkort B.Correlation between rheological parameters and erythrocyte velocity in nailfold capillaries in patients with diabetes mellitus.Clin Hemorheol Microcirc,1999,20(1):41~7 被引量:1
  • 3[3]Drozdz W,Panek J,Lejman W.Red cell deformability in patients with chronic atheromatous ischemia of the legs. Med Sci Monit, 2001,7(5):933~9 被引量:1
  • 4[4]Rim SJ,Leong-Poi H,Lindner JR,et al. Decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity.:Circulation,2001,104(22):2704~9 被引量:1
  • 5[5]Banyai S,Banyai M,Falger J,et al. Atorvastatin improves blood rheology in patients with familiar hypercholesterolemia (FH) on long-term LDL apheresis treatment. Atherosclerosis,2001,159(2):513~9 被引量:1
  • 6姚成芳,蔡生业,王丽.复方花刺参制剂抗凝血机制的实验研究[J].中国海洋药物,2000,19(1):33-35. 被引量:12

二级参考文献4

  • 1马克韶 郝晓阁 王莉.刺参酸性粘多糖抗肿瘤转移的实验研究[J].海洋药物,1982,1(1):10-10. 被引量:1
  • 2赵水平,临床血脂学,1997年,224页 被引量:1
  • 3金伯泉,细胞和分子免疫学,1995年,42页 被引量:1
  • 4马克韶,海洋药物,1982年,1期,10页 被引量:1

共引文献11

同被引文献17

  • 1Prati F, Imola F, Corvo P, et al. The restart project : high-dose atorvastatin helps control restenosis after stenting procedures at high risk for resteno- sis. Results from a prospective study and a matched control group com- parison[ J]. Euro Intervention, 2007,3 ( 1 ) :89-94. 被引量:1
  • 2Qin cc, Liu ZH. In atherogenesis, the apoptosis of endothelial cell itself could directly induce over-proliferation of smooth muscle cells[ J]. Med Hypotheses, 2007, 68 (2) : 275-277. 被引量:1
  • 3Napoli C,de Nigris F,Williams-Ignarro S,et al. Nitric oxide and athero- sclerosis:an update[ J]. Nitric Oxide,2006,15 (4) :265-279. 被引量:1
  • 4Waidow T, Witt W, Weber E, et at. Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NF-kappaB activation in endothelial cells ~ J ]. Nitric Oxide, 2006,15 ( 2 ) : 103 - 113. 被引量:1
  • 5Bohm F,Pernow J. The importance of endothe lin-1 for vascular dysfunc- tion in cardiovascular disease [ J ]. Cardiovasc Res,2007,76 ( 1 ) : 8-18. 被引量:1
  • 6Strijdom H, Chamane N, Lochner A. Nitric oxide in the cardiovascul. system:a simple molecule with complex actions [ J ]. Cardiovasc J Aft, 2009, 20 ( 5 ) :303-310. 被引量:1
  • 7Li H, Forstermann U. Prevention of atherosclerosis by interference with the vascular nitrc oxide system[ J]. Curr Pharm Des,2009, 15 (27) : 3133-3145. 被引量:1
  • 8Petkova SB, Huang H, Factor SM, et al. The role of endothelin in the pathogenesis of chagas disease [ J ]. Int J Parasitol, 2001, 31 ( 5 45 ) : 499-511. 被引量:1
  • 9Wildgruber M, Weiss W, Berger H, et al. Transforming growth factor beta, tumor necrosis factor alpha and basic fihroblast growth factor with restenosis after transluminal angioplasty [ J ]. Eur J Vasc Endovasc Surg, 2007, 34( 1 ) :35-43. 被引量:1
  • 10Montalescot G, Philippe F, Ankri A, et al. Early increase of von wille- brand factor predicts adverse outcome in unstable coronary artery dis- ease : beneficial effects of enoxaparin[ J ]. Circulation, 1998, 98 ( 4 ) : 294-299. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部